Umbilical Cord Blood-Derived Therapies as a Treatment for Graft-Versus-Host Disease

doi 10.5772/64945
Full Text
Abstract

Available in full text

Date
Authors
Publisher

InTech

Related search

Treatment of Leukemic Relapse Following Unrelated Umbilical Cord Blood Transplantation With Interleukin-2: Potential for Augmenting Graft-Versus-Leukemia and Graft-Versus-Host Effects With Cytokines

Bone Marrow Transplantation
TransplantationHematology
2000English

Ruxolitinib as a Promising Treatment for Corticosteroid-Refractory Graft-Versus -Host Disease

British Journal of Haematology
Hematology
2017English

Tacrolimus for Prevention of Graft-Versus-Host Disease After Mismatched Unrelated Donor Cord Blood Transplantation

Bone Marrow Transplantation
TransplantationHematology
1999English

Graft-Versus-Host Disease

New England Journal of Medicine
Medicine
1991English

Graft Versus Host Disease

2020English

Graft Versus Host Disease

Bone Marrow Transplantation
TransplantationHematology
2000English

Updated Experience With Inolimomab as Treatment for Corticosteroid-Refractory Acute Graft-Versus-Host Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Treatment of Chronic Graft-Versus-Host Disease in 2011

Current Opinion in Hematology
Hematology
2011English

Sirolimus for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease

Bone Marrow Transplantation
TransplantationHematology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy